The Combi40+ cochlear implant device manufactured by MED-EL has such advantages as having a long electrode with 12 channels which can be inserted deep into cochlea and being capable of a very fast stimulation using CIS coding. This device is widely adopted all over world, especially in Europe. We implanted this Combi40+ device into the cochleae of four postlingually deaf adults and reported the results in the early period. No postoperative complication was observed for about one year. The speech comprehension ability was comparable to other devices of the different manufacturers, and the patients expressed a high degree of satisfaction with the cochlear implant. We consider that the Combi40+ device is as safe and efficient as the other devices currently employed in our country.
